H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,444 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
根據最新的財務報表(Form-10K),H.U. Group Holdings, Inc. 的總資產為 $279,582,淨isProfitable}為 $2,761
MRCHF 的關鍵財務比率是什麼?
H.U. Group Holdings, Inc. 的流動比率為 1.96,淨利潤率為 1.13,每股銷售為 $4,277.2。
H.U. Group Holdings, Inc. 的收入按細分市場或地理位置如何劃分?
H.U. Group Holdings, Inc. 最大收入來源為 Inspection and Related Service,在最近的收益報告中收入為 153,014,000,000。就地區而言,Japan 是 H.U. Group Holdings, Inc. 的主要市場,收入為 206,215,000,000。
H.U. Group Holdings, Inc. 是否盈利?
是的,根據最新的財務報表,H.U. Group Holdings, Inc. 的淨利潤為 $2,761